Literature DB >> 24854435

NMR metabolomics of human blood and urine in disease research.

Iola F Duarte1, Sílvia O Diaz2, Ana M Gil2.   

Abstract

This paper reviews the main applications of NMR metabolomics of blood and urine in disease research, over the last 5 years. The broad range of disease types addressed attests the increasing interest within the academic and medical communities to explore the recognised potential of metabolomics to (1) provide insight into underlying disease pathogenesis and (2) unveil new metabolic markers for disease diagnosis and follow up. Importantly, most recent studies reveal an increasing awareness of possible limitations and pitfalls of the metabolomics approach, together with efforts for improved study design and statistical validation, which are crucial requisites for the sound development of NMR metabolomics and its progress into the clinical setting.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood; Disease; Metabolomics; NMR spectroscopy; Urine

Mesh:

Substances:

Year:  2013        PMID: 24854435     DOI: 10.1016/j.jpba.2013.09.025

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  24 in total

1.  Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

Authors:  Jasmohan S Bajaj; I Jane Cox; Naga S Betrapally; Douglas M Heuman; Mitchell L Schubert; Maiyuran Ratneswaran; Phillip B Hylemon; Melanie B White; Kalyani Daita; Nicole A Noble; Masoumeh Sikaroodi; Roger Williams; Mary M E Crossey; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-25       Impact factor: 4.052

2.  Plasma metabolic profiling analysis of neurotoxicity induced by oxaliplatin using metabonomics and multivariate data analysis.

Authors:  Yanyan Xu; Yiwei Zhao; Xuejun Guo; Yubo Li; Yanjun Zhang
Journal:  Toxicol Res (Camb)       Date:  2018-04-27       Impact factor: 3.524

Review 3.  Emerging new strategies for successful metabolite identification in metabolomics.

Authors:  Kerem Bingol; Lei Bruschweiler-Li; Dawei Li; Bo Zhang; Mouzhe Xie; Rafael Brüschweiler
Journal:  Bioanalysis       Date:  2016-02-26       Impact factor: 2.681

4.  Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic Osteoarthritis.

Authors:  Beata Mickiewicz; Sung Y Shin; Ambra Pozzi; Hans J Vogel; Andrea L Clark
Journal:  J Proteome Res       Date:  2016-01-28       Impact factor: 4.466

Review 5.  Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer.

Authors:  Bo Yang; Guo-Qiang Liao; Xiao-Fei Wen; Wei-Hua Chen; Sheng Cheng; Jens-Uwe Stolzenburg; Roman Ganzer; Jochen Neuhaus
Journal:  J Zhejiang Univ Sci B       Date:  2017 Nov.       Impact factor: 3.066

6.  Nuclear magnetic resonance-based metabolomic investigation reveals metabolic perturbations in PM2.5-treated A549 cells.

Authors:  Dacheng Huang; Yajuan Zou; Anees Abbas; Bona Dai
Journal:  Environ Sci Pollut Res Int       Date:  2018-09-12       Impact factor: 4.223

Review 7.  Two elephants in the room: new hybrid nuclear magnetic resonance and mass spectrometry approaches for metabolomics.

Authors:  Kerem Bingol; Rafael Brüschweiler
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-09       Impact factor: 4.294

8.  Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkers.

Authors:  He Wen; Tack Lee; Sungyong You; Soo-Hwan Park; Hosook Song; Karyn S Eilber; Jennifer T Anger; Michael R Freeman; Sunghyouk Park; Jayoung Kim
Journal:  J Proteome Res       Date:  2014-11-18       Impact factor: 4.466

Review 9.  Lipid and Metabolic Changes in Rheumatoid Arthritis.

Authors:  Catherine M McGrath; Stephen P Young
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

Review 10.  Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy.

Authors:  Farhad Dastmalchi; Loic P Deleyrolle; Aida Karachi; Duane A Mitchell; Maryam Rahman
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.